R
Revolution Medicines D
D
RVMD
37.920
USD
0.73
(1.96%)
مغلق
حجم التداول
0
الربح لكل سهم
-5
العائد الربحي
-
P/E
-9
حجم السوق
7,063,265,268
الأخبار المقالات
العنوان: Revolution Medicines
القطاع: Healthcare
الصناعة: Biotechnology
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.